HCM
TMO icon

Highbridge Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Highbridge Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,300
Closed -$325K – 1814
2015
Q4 		$325K Buy
+2,300
New +$307K 0.01% 1160
2015
Q1 		– Sell
-9,400
Closed -$1.18M – 1587
2014
Q4 		$1.18M Buy
+9,400
New +$1.14M 0.02% 601

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Highbridge Capital Management's TMO Position: Q3 2018 in Review

Highbridge Capital Management sold out of Thermo Fisher Scientific (TMO) in Q3 2018, closing a stake of 8,778 shares — an estimated $1.82M sold.

Highbridge Capital Management first reported a position in TMO in Q1 2014 and held it in 8 quarters. The position peaked at $12.5M in Q2 2015. 1,350 funds tracked by Wall St. Rank hold TMO as of Q3 2018.

  • Highbridge Capital Management reported no remaining Thermo Fisher Scientific position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 8,778 Thermo Fisher Scientific shares in Q3 2018, an estimated $1.82M.
  • Highbridge Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 8 quarters.
  • Highbridge Capital Management's Thermo Fisher Scientific position peaked at $12.5M in Q2 2015.
  • 1,350 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.